Schedule 13G ownership disclosure

Ironwood Pharmaceuticals Inc

COMMON STOCK · CUSIP: 46333X108

Event date: 2025-03-31

Filing-level shares
3,498,289.00
Percent of class
2.2%
  • STATE STREET CORPORATION

    Shares: 3,498,289.00 · Class: 2.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000093751-25-000283
Form type
SCHEDULE 13G
Filer
IRONWOOD PHARMACEUTICALS INC
CIK
CIK 1446847
Filed
May 13, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub